Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

Background/Aims This study aimed to compare the diagnostic performances of Liver Imaging Reporting and Data System (LI-RADS) 2018 and Korean Liver Cancer Association-National Cancer Center (KLCA-NCC) 2018 criteria on magnetic resonance imaging (MRI) for the noninvasive diagnosis of hepatocellular ca...

Full description

Bibliographic Details
Main Authors:	Sunyoung Lee, Seung-seob Kim, Dong ryul Chang, Hyerim Kim, Myeong-Jin Kim
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2020-07-01
Series:	Clinical and Molecular Hepatology
Subjects:	carcinoma, hepatocellular diagnosis magnetic resonance imaging
Online Access:	http://e-cmh.org/upload/pdf/cmh-2020-0004.pdf

Similar Items

Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
by: Ja Kyung Yoon, et al.
Published: (2023-03-01)

Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis
by: Dong Hwan Kim, et al.
Published: (2021-09-01)

Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
by: Hyo-Jin Kang, et al.
Published: (2023-10-01)

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Published: (2023-03-01)

Impact of the updated KLCA-NCC criteria for diagnosis of “probable HCC” in liver MRI: comparisons between KLCA v2022 and v2018
by: Jeong Hee Yoon
Published: (2023-03-01)

The Diagnostic Efficacy of Version 2018 LI-RADS for Hepatocellular Carcinoma on Enhanced Magnetic Resonance Imaging
by: Sulan JIA, et al.
Published: (2023-01-01)

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
by: Haiping Zhang, et al.
Published: (2022-04-01)

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
by: Tae-Hyung Kim, et al.
Published: (2019-09-01)

A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma
by: Yingying Liang, et al.
Published: (2024-01-01)

Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma
by: Granata Vincenza, et al.
Published: (2020-05-01)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
by: Moura Cunha G, et al.
Published: (2021-05-01)

Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm
by: Xi Zhong, et al.
Published: (2021-04-01)

Performance of HCC diagnosis in the KLCA-NCC guidelines: a closer look at MRI contrast agents and HCC imaging hallmarks
by: Ji Hye Min, et al.
Published: (2024-03-01)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
by: Zhe Huang, et al.
Published: (2023-03-01)

Noninvasive diagnosis of hepatocellular carcinoma
by: Byung Seok Kim
Published: (2012-06-01)

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
by: Nicolas Voizard, et al.
Published: (2019-12-01)

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
by: Chansik An, et al.
Published: (2016-06-01)

Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial
by: Chansik An, et al.
Published: (2018-09-01)

Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
by: Ahmed Haitham Abduljabbar, et al.
Published: (2023-08-01)

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
by: Xinai Liu, et al.
Published: (2022-07-01)

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
by: Federica Vernuccio, et al.
Published: (2022-05-01)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
by: Ruizhi Wang, et al.
Published: (2023-02-01)

Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
by: Li Y, et al.
Published: (2023-03-01)

US LI-RADS visualization score: diagnostic outcome of ultrasound-guided focal hepatic lesion biopsy in patients at risk for hepatocellular carcinoma
by: Ji Hun Kang, et al.
Published: (2021-01-01)

Complementary Role of CEUS and CT/MR LI-RADS for Diagnosis of Recurrent HCC
by: Mei-Qing Cheng, et al.
Published: (2023-12-01)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
by: Katsutoshi Sugimoto, et al.
Published: (2020-10-01)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
by: Yan Zhou, et al.
Published: (2022-05-01)

The role of dynamic and diffusion MR imaging in therapeutic response assessment after microwave ablation of hepatocellular carcinoma using LI-RADS v2018 treatment response algorithm
by: Bahaa Eldin Mahmoud, et al.
Published: (2021-02-01)

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
by: Yan Zhou, et al.
Published: (2022-03-01)

Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Dong Hwan Kim, et al.
Published: (2021-09-01)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
by: Katsutoshi Sugimoto, et al.
Published: (2023-07-01)

Noninvasive diagnostic criteria for hepatocellular carcinoma
by: Han Chu Lee
Published: (2012-06-01)

Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
by: Yoon Jung Hwang, et al.
Published: (2023-07-01)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
by: Yi-Xin Hu, et al.
Published: (2021-04-01)

Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study
by: Sébastien Mulé, et al.
Published: (2023-10-01)

2018 Korean Liver Cancer Association and National Cancer Center for Clinical Practice Guidelines of Hepatocellular Carcinoma: What’s Different from 2014?
by: Ji Hoon Kim
Published: (2019-08-01)

Recent Updates of Abbreviated MRI for Hepatocellular Carcinoma Screening
by: Jeong Woo Kim, et al.
Published: (2021-03-01)

LI-RADS ancillary features on contrast-enhanced ultrasonography
by: Christoph F. Dietrich, et al.
Published: (2020-07-01)

Value of Image Subtraction for the Identification of Hepatocellular Carcinoma Capsule on Gadoxetic Acid-Enhanced MRI
by: Hyunjung Kim, et al.
Published: (2018-12-01)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
by: Ying Ding, et al.
Published: (2018-12-01)